ESTUTC-5 New YorkLog in Sign up

ABCL
AbCellera Biologics Inc. Common Shares
stockNASDAQ

Market OpenNov 10, 2026 1:56:41 PM EST

12.14USD-2.920%(-0.36)2,273,238

Pre-marketNov 10, 2026 9:28:30 AM EST

12.32USD-1.440%(-0.18)

12.11Bid12.58Ask0.47Spread

ABCL News

Day breaks

10:04 AM ESTAbCellera Biologics Inc (ABCL) (Q3 2026) Earnings Call Highlights: Breakthrough Hot Flash Data ... ·

GuruFocus

09:01 AM ESTABCL Maintained by Stifel -- Price Target Raised to $14.00 ·

GuruFocus

01:42 AM ESTAbCellera (ABCL) Q3 2026 Earnings Call Transcript ·

The Motley Fool+1 source

12:05 AM ESTABCL SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing ·

GuruFocus

11:57 PM ESTAbCellera Biologics (ABCL) Reports Promising Phase II Data and Raises $200M Capital ·

GuruFocus

11:11 PM ESTAbCellera outlines plans to initiate ABCL635 late-stage development in 2027, while citing liquidity for at least the next 3 years ·

Seeking Alpha

11:10 PM ESTAbCellera Biologics Inc. (ABCL) Q3 2026 Earnings Call Transcript ·

Seeking Alpha

11:00 PM ESTQ3 2026 AbCellera Biologics Inc. Earnings Call Transcript ·

GuruFocus

09:57 PM ESTAbCellera Biologics Inc Q3 Loss Decreases ·

RTTNews

04:50 PM ESTAbCellera Reports Q3 2026 Financial Results: Revenue at $10. ... ·

GuruFocus

04:19 PM ESTAbCellera Biologics GAAP EPS of -$0.13 beats by $0.05, revenue of $10.6M beats by $4.35M ·

Seeking Alpha

10:00 AM ESTHere are the major earnings after the close Monday ·

Seeking Alpha

09:51 AM ESTAbcellera Biologics earnings on deck as ABCL635 takes spotlight ·

Investing.com

05:59 PM ESTAbCellera Biologics (ABCL) Prepares to Report Q3 Earnings Amid Declining Revenue Forecasts ·

GuruFocus

10:00 AM ESTQuant snapshot: Aveanna Healthcare and Fossil lead top-rated names, as KBC Group and DeFi Development lag ·

Seeking Alpha

04:18 PM EDTAbCellera to Present at Upcoming Investor Conferences in November 2026 ·

Financial Post

04:08 PM EDTAbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting ·

Financial Post

04:11 PM EDTAbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026 ·

Financial Post

12:36 PM EDTAbcellera Biologics stock hits 52-week high at 13.23 USD ·

Investing.com